Equity Investing
AstraZeneca (AZN) Sold its Moderna (MRNA)Stack for Over $1 Billion
AstraZeneca (AZN), a British drug company, sold 1.2 billion dollars worth of its shares in Moderna (mRNA). With 7.7% of the shares, the company was
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.